3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
7
Phase 2
3
Phase 2/3
2
Phase 1/2
1
Status
Recruiting
2
Sponsor Class
INDUSTRY
2
Study Type
Interventional
2
Sponsor
Cancer Type
Thoracic
1
Gastrointestinal
1
Conditions
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Interventions
Cisplatin
30
Magnetic Resonance Spectroscopy
23
Carboplatin
23
pembrolizumab
21
Paclitaxel
20
Gemcitabine
19
Specimen Handling
16
Drug Therapy
15
Dexamethasone
15
Radiotherapy
14
Nivolumab
14
Doxorubicin
14
Bevacizumab
14
atezolizumab
13
Oxaliplatin
13
Cyclophosphamide
13
Radiation
11
Pemetrexed
11
Cytarabine
11
venetoclax
10
Vincristine
10
Prednisone
10
Docetaxel
10
Capecitabine
10
Trastuzumab
9
Temozolomide
8
Rituximab
8
Platinum
8
Ipilimumab
8
Fluorouracil
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2/3
×
budigalimab
×
1 year
×
Clear all
NCT06236438
2026-02-23
LIVIGNO-4
AbbVie
Phase 2/3
Recruiting
840 enrolled
NCT06109272
2025-08-15
LIVIGNO-2
AbbVie
Phase 2/3
Recruiting
660 enrolled